Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The interest coverage ratio is N/A as of Tuesday, October 6, 2026.
INTEREST COVERAGE RATIO
N/A
Aptevo Therapeutics Inc.
Market Cap
$3.94M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.32M
Interest Coverage Ratio
-21.32x
TTM Avg
128.62x
3Y Avg
128.62x
5Y Avg
128.62x
Market Cap
$3.47M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.41M
Interest Coverage Ratio
-345.15x
TTM Avg
1.19x
3Y Avg
1.19x
5Y Avg
1.19x
Market Cap
$4.42M
Interest Coverage Ratio
-765.53x
TTM Avg
1.76x
3Y Avg
1.76x
5Y Avg
1.76x
Market Cap
$3.44M
Interest Coverage Ratio
-507.49x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | $3.94M | N/A | N/A | N/A | N/A |
| GRI Bio, Inc. (GRI)vs › | $4.18M | N/A | N/A | N/A | N/A |
| Eocene Ltd. (EOCN)vs › | $3.59M | N/A | N/A | N/A | N/A |
| 20/20 Biolabs Inc. (AIDX)vs › | $4.32M | -21.32x | 128.62x | 128.62x | 128.62x |
| Evogene Ltd. (EVGN)vs › | $3.48M | -7.42x | N/A | N/A | N/A |
| IceCure Medical Ltd (ICCM)vs › | $3.47M | N/A | N/A | N/A | N/A |
| Ernexa Therapeutics Inc. (ERNA)vs › | $4.41M | -345.15x | 1.19x | 1.19x | 1.19x |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.42M | -765.53x | 1.76x | 1.76x | 1.76x |
| Aethlon Medical, Inc. (AEMD)vs › | $3.44M | -507.49x | N/A | N/A | N/A |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.46M | N/A | N/A | N/A | N/A |
Interest Coverage
N/A
Debt/Equity
0.70
Current Ratio
2.08
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
